Optimizing Outcomes in Myeloma
Dr. Peter Voorhees and Amy Pierre discuss the evolving landscape of myeloma, covering early signs, diagnostics, frontline therapy, transplant decisions, and T-cell redirecting therapies. They also address survivorship challenges, treatment toxicity, and disparities in access to…